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Abstract
Background: Nearly 1% of children in the United States exhibit autism spectrum disorders, but causes and treatments
remain to be identified. Mice with deletion of the fragile X mental retardation 1 (Fmr1) gene are used to model autism
because loss of Fmr1 gene function causes Fragile X Syndrome (FXS) and many people with FXS exhibit autistic-like
behaviors. Glycogen synthase kinase-3 (GSK3) is hyperactive in brains of Fmr1 knockout mice, and inhibition of GSK3 by
lithium administration ameliorates some behavioral impairment in these mice. We extended our studies of this association
by testing whether GSK3 contributes to socialization behaviors. This used two mouse models with disrupted regulation of
GSK3, Fmr1 knockout mice and GSK3 knockin mice, in which inhibitory serines of the two isoforms of GSK3, GSK3a and
GSK3b, are mutated to alanines, leaving GSK3 fully active.
Methodology/Principal Findings: To assess sociability, test mice were introduced to a restrained stimulus mouse (S1) for
10 min, followed by introduction of a second restrained stimulus mouse (S2) for 10 min, which assesses social preference.
Fmr1 knockout and GSK3 knockin mice displayed no deficit in sociability with the S1 mouse, but unlike wild-type mice
neither demonstrated social preference for the novel S2 mouse. Fmr1 knockout mice displayed more anxiety-related
behaviors during social interaction (grooming, rearing, and digging) than wild-type mice, which was ameliorated by
inhibition of GSK3 with chronic lithium treatment.
Conclusions/Significance: These results indicate that impaired inhibitory regulation of GSK3 in Fmr1 knockout mice may
contribute to some socialization deficits and that lithium treatment can ameliorate certain socialization impairments. As
discussed in the present work, these results suggest a role for GSK3 in social behaviors and implicate inhibition of GSK3 as a
potential therapeutic.
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Introduction
Autism Spectrum Disorders (ASDs) are a group of neurodevel-
opmental disorders characterized by deficits in social interactions
and communication, and displays of repetitive behaviors. ASD is
one of the most common behavioral disabilities diagnosed in
children aged 3–5, 1 in 150 children in the United States was
diagnosed with ASD in 2007 [1,2], and the Centers for Disease
Control and Prevention estimates that currently approximately 1
in 110 children in the United States has an ASD. Still-undefined
combinations of genetic and environmental factors are thought to
cause ASDs, and more effective treatments than those currently
available are needed.
Animal models of ASDs are vital for studying the molecular
mechanisms of the disorder and for developing effective
therapeutics. Patients with Fragile X syndrome (FXS), caused by
loss of function of the fragile X mental retardation 1 (Fmr1) gene [3],
often exhibit many of the symptoms commonly associated with
ASDs, such as developmental delays, communication impair-
ments, and anxiety [4–11]. These overlaps have led many
investigators to conclude that Fmr1 knockout mice provide a
unique opportunity to identify interventions that affect autistic-like
behaviors [12–14]. It is particularly relevant that Fmr1 knockout
mice have been found to display several deficits in social behaviors,
including social dominance, social interest, social interaction, and
social recognition, although differences in these behaviors have
varied among the reports [12,13,15–19], as noted in the
Discussion.
In Fmr1 knockout mice, the FXS-related behaviors of sensitivity
to audiogenic seizures, hyperactivity, and impaired passive
avoidance memory were recently found to be effectively
ameliorated by lithium [20,21], an inhibitor of glycogen synthase
kinase-3 (GSK3) that has been used in bipolar patients for many
years [22]. Although GSK3 was first identified as an enzyme
phosphorylating glycogen synthase, it has since been found to
phosphorylate over 50 substrates [23]. Via substrate phosphory-
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development, cell structure, microtubule dynamics, gene expres-
sion, and cell survival [24,25]. GSK3 is a ubiquitous serine/
threonine kinase that is present in mammals in two paralogs
encoded by different genes that are commonly referred to as
GSK3 isoforms, GSK3a and GSK3b [26]. Unlike many kinases
that require a signal to be activated, GSK3 is constitutively
partially active; therefore, signals impinging on GSK3 can either
decrease or increase its activity. The most prevalent mechanism
regulating the activity of GSK3 is inhibition by phosphorylation
on serine-21 of GSK3a and serine-9 of GSK3b. Several kinases
mediate this serine-phosphorylation, which greatly inhibits the
activity of GSK3 [23]. A recently identified deficit in inhibitory
serine-phosphorylation of GSK3 in Fmr1 knockout mice raised the
possibility that dysregulated GSK3 contributes to some of the
behavioral phenotypes of these mice [20,21]. The importance of
inhibitory control of GSK3 can be studied using homozygous
GSK3a
21A/21A/b
9A/9A knockin mice, where the regulatory serines
of both GSK3 isoforms are mutated to alanines [27]. These
mutations maintain GSK3 maximally active, but importantly
within the physiological range since both GSK3 isoforms are
expressed at normal levels. Inhibitory serine-phosphorylation of
GSK3 also is important for the action of lithium. Although lithium
is a direct inhibitor of GSK3 [28,29], at concentrations achieved
in humans this is only a weak inhibition that is amplified by
lithium-induced increases in inhibitory serine-phosphorylation of
GSK3 [22,30]. Thus, lithium treatment can reverse the deficit in
serine-phosphorylated GSK3 in Fmr1 knockout mice [20,21], but
this action is blocked in GSK3 knockin mice.
Since Fmr1 knockout mice display social behavior deficits
[13,16,17,19], GSK3 is hyperactive in some brain regions of Fmr1
knockout mice, and the GSK3 inhibitor lithium ameliorates
several other impaired behaviors in Fmr1 knockout mice [20,21],
the current study tested the hypothesis that impaired inhibitory
regulation of GSK3 may contribute to deficits in sociability
behaviors in Fmr1 knockout mice. To do this, we tested whether
administration of the GSK3 inhibitor lithium [28,29], which
increases inhibitory serine-phosphorylation of GSK3 ([20,21,30],
restored normal social behaviors in Fmr1 knockout mice, and
tested whether GSK3 knockin mice, which completely lack the
GSK3 inhibitory serine-phosphorylation, displayed any abnormal
social behaviors that were similar to those of Fmr1 knockout mice.
The results indicate that GSK3 contributes to a subset of social
behavioral deficits in Fmr1 knockout mice, including impaired
social preference and increased anxiety-related behaviors during
social interaction.
Results
Sociability is similar in Fmr1 knockout mice and wild-type
mice and is increased by chronic lithium treatment
Wild-type and Fmr1 knockout mice littermates (Fig. 1B) (,3
months old) were individually placed in a social interaction
apparatus to assess social behaviors, including sociability (prefer-
ence for the chamber with an introduced mouse), social approach
(number of nose contacts with an introduced mouse), and social
interaction (duration of nose contacts). The sociability assessment
involved the presence of a single wild-type stimulus mouse (S1)
contained in a wire enclosure within Chamber 1 (Fig. 1). Chamber
2 was completely empty and Chamber 3 contained an empty wire
cage enclosure. Both wild-type (Fig. 1C) and Fmr1 knockout
(Fig. 1D) mice displayed equivalent significant preferences for
spending time in Chamber 1, with stimulus mouse (S1), compared
with Chambers 2 or 3, and there was no significant interaction
between genotype and chamber (F(2, 48),0, P=0.994). Chronic
lithium treatment, which increased the inhibitory serine-phos-
phorylation of GSK3b in the brains of wild-type mice (Fig. 1B)
[21], had no significant effect on sociability (Fig. 1C, black bars;
F(1, 36),0, P=1) compared to untreated wild-type mice. In
contrast, there was a significant interaction between lithium
treatment and chamber among Fmr1 knockout mice (Fig. 1D, F(2,
39)=16.75, P,0.001). Lithium treatment promoted sociability in
Fmr1 knockout mice, significantly increasing the time Fmr1
knockout mice spent in Chamber 1 with the stimulus mouse
(Fig. 1D, slashed bars; F(2, 39)=139.49, P,0.001), and
significantly decreasing time spent in empty Chamber 3 (Fig. 1D,
F(2, 39)=139.49, P=0.001) compared to untreated Fmr1
knockout mice (Fig. 1D gray bars).
Sociability was further assessed by measuring social approach
and social interaction. Social approach, quantitated as the number
of nose contacts with the S1 stimulus mouse, was equivalent in
untreated wild-type and Fmr1 knockout mice (Fig. 1E, t(15)=1.35,
P=0.197). Chronic lithium treatment significantly increased social
approach, evident by increased number of nose contacts with S1
mouse, in wild-type mice (t(12)=3.08, P=0.01) and in Fmr1
knockout mice (t(12)=3.33, P=0.006). This effect of lithium is
unlikely due to increased activity of the mice because lithium
administration did not alter the open field activity of wild-type
mice and reduced activity of Fmr1 knockout mice [20,21]. The
genotypes differed in social interaction, quantitated by the
duration of nose contacts with the S1 mouse, which was
significantly lower in Fmr1 knockout mice than in wild-type mice
(Fig. 1F, t(16)=2.30, P=0.035). Chronic lithium treatment had no
significant effect on social interaction between wild-type mice and
the S1 mouse (t(12)=1.57, P=0.142) or Fmr1 knockout mice and
the S1 mouse (t(12)=0.462, P=0.653). Thus, Fmr1 knockout mice
displayed a deficit in social interaction, and chronic lithium
treatment increased sociability in Fmr1 knockout mice and social
approach in both groups of mice.
Fmr1 knockout mice exhibit impaired social interaction
with a novel mouse, which is ameliorated by lithium
treatment
Social preference was measured by placing another stimulus
mouse (S2) in Chamber 3 and comparing the interactions of wild-
type and Fmr1 knockout mice with the familiar S1 mouse and the
novel S2 mouse. There was an overall significant interaction
between genotype and chamber among wild-type and Fmr1
knockout mice (F(2, 48)=5.66, P=0.006). As shown in Figure 2A
(open bars), wild-type mice spent significantly more time in
Chamber 3 with the novel S2 mouse than in Chamber 1 with the
familiar S1 mouse or in the empty Chamber 2 (F(2, 36)=50.40,
P,0.001). Chronic lithium treatment caused no significant
interaction between treatment and chamber and no significant
change in sociability among wild-type mice (Fig. 2A, black bars;
F(2, 36)=0.95, P=0.396). Untreated Fmr1 knockout mice did not
display a significant preference for the novel S2 mouse compared
with the familiar S1 mouse, as there was no significant difference
in the amount of time spent in Chamber 1 and Chamber 3
(Fig. 2B, gray bars; F(2, 39)=19.77, P=0.151). Thus, although
Fmr1 knockout mice displayed no deficits in sociability compared
with wild-type mice during period 1, Fmr1 knockout mice did not
display a preference for the novel mouse during period 2, thereby
suggesting a deficit in social preference. Chronic lithium treatment
did not promote a significant interaction between treatment and
chamber (Fig. 2B, F(2, 39)=1.39, P=0.261), and did not cause
significant differences in the times that Fmr1 knockout mice spent
in Chamber 3 with the novel S2 mouse, compared to Chamber 1
FX Social Behavior
PLoS ONE | www.plosone.org 2 March 2010 | Volume 5 | Issue 3 | e9706Figure 1. Influences of lithium treatment on the sociability of Fmr1 knockout and wild-type mice. A. Diagram of the social interaction
apparatus. The ovals represent the wire enclosures used to secure the stimulus mice, S1 in Chamber 1 and S2 in Chamber 3. The breaks in the center
walls represent the circular openings allowing the mice to move between chambers. B. Representative image of genotyping results from wild-type
and Fmr1 knockout mice (top). Chronic lithium treatment increased inhibitory serine-phosphorylation of GSK3 (PS-GSK3) on serine-21 of GSK3a and
on serine-9 of GSK3b in the hippocampus of wild-type and Fmr1 knockout mice (bottom) as reported previously [20,21]. C. Mean total time spent by
wild-type mice in each chamber during the sociability period. Wild-type (WT) (n=9) mice spent significantly more time in Chamber 1, the chamber
with S1, compared to empty Chamber 2 or Chamber 3 with the wire enclosure only. Chronic lithium treatment of WT mice (n=5) had no significant
effect on sociability. * p,0.05 comparing time spent in Chamber 1 with time in Chambers 2 and 3. D. Mean total time spent by Fmr1 knockout mice
in each chamber during the sociability period. Fmr1 knockout (FX) mice (n=9) spent significantly more time in Chamber 1, the chamber with S1,
compared to empty Chamber 2 or Chamber 3 with the wire enclosure only. FX mice (n=6) chronically treated with lithium displayed a significant
FX Social Behavior
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P=0.232).
In social approach, as measured by the number of nose contacts
with S1 or S2, there was no significant interaction between
genotype and stimulus mouse (or chamber of interaction) among
wild-type and Fmr1 knockout mice (Fig. 2C, F(1, 32)=2.98,
P=0.094). Wild-type mice, however, showed a significant
preference for approaching S2 in Chamber 3, compared to S1
(F(1, 32)=6.282, P=0.005). Chronic lithium treatment of wild-
type mice did not induce a significant interaction between
treatment and stimulus mouse (or chamber of interaction; F(1,
24)=0.257, P=0.617), but caused a significant increase in the
social approach of wild-type mice with S2, thereby increasing the
number of nose contacts with S2 (F(1, 24)=17.13, P=0.030).
Lithium treatment of Fmr1 knockout mice did not induce any
significant interaction between treatment and stimulus mouse (or
Figure 2. Fmr1 knockout mice exhibit impairments in social preference. A. Mean total time spent by wild-type mice in each chamber during
the social preference period. Wild-type (WT) mice (n=9) spent significantly more time in Chamber 3 with the novel S2 mouse compared to empty
Chamber 2, or to Chamber 1 with the familiar S1 mouse. Chronic lithium treatment did not significantly alter time spent in each chamber (n=5). *
p,0.05 comparing time spent in Chamber 3 with Chambers 1 and 2. B. Mean total time spent by Fmr1 knockout mice in each chamber during the
social preference period. There was not a significant difference in the amount of time Fmr1 knockout (FX) mice (n=9) spent in Chamber 3 with the
novel mouse S2 and in Chamber 1 with the familiar mouse S1. Chronic lithium treatment did not significantly alter time spent in each chamber (n=6).
C. WT mice, but not FX mice, displayed a significant preference for nose contacts with S2, compared to S1. Chronic lithium treatment significantly
increased the number of nose contacts with S2 by both WT and FX mice. * p,0.05 nose contacts with S2 compared with S1; ** p,0.05 compared to
nose contacts with S2 by untreated group mates. D. The duration of nose contacts with S1 and S2 was not significantly different between WT and FX
mice. Chronic lithium treatment had no significant effect on nose contact duration.
doi:10.1371/journal.pone.0009706.g002
increase in time spent in Chamber 1, with S1, as compared to time in Chambers 2 or 3. Treated mice also displayed a significant increase in time spent
in Chamber 1 and a significant decrease in time spent in Chamber 3, as compared to untreated controls. * p,0.05 comparing time spent in Chamber
1 with Chambers 2 and 3; # p,0.05 compared to untreated FX mice. E. The total number of nose contacts by the test mouse with S1 was equivalent
for untreated WT and FX mice. Chronic lithium treatment significantly increased the number of nose contacts for both WT and FX mice. * p,0.05
compared to untreated group mates. F. The duration of nose contacts with S1 was lower in FX than WT mice. Lithium treatment had no effect on
social interaction (defined as the average duration of nose contacts). * p,0.05 compared to untreated WT mice.
doi:10.1371/journal.pone.0009706.g001
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after lithium treatment Fmr1 knockout mice displayed a significant
increase in nose contacts with S2 compared to S1 (F(1, 26)=4.24,
P=0.03). Thus, lithium appears to correct the deficit in social
preference among Fmr1 knockout mice, as a significant difference
in social preference for S2 occurred after treatment.
There was no significant interaction between genotype and
stimulus mouse (or chamber of interaction) in social interaction,
the duration of nose contacts (Fig. 2D, F(1, 32)=0, P=0.952.
Chronic lithium treatment of wild-type mice did not induce a
significant interaction between treatment and stimulus mouse (or
chamber of interaction), as shown in Fig. 2D (F(1, 24)=0.274,
P=0.605). Lithium treatment of Fmr1 knockout mice did not
cause a significant difference in social interaction and did not
induce a significant interaction between treatment and stimulus
mouse (or chamber or interaction) (F(1, 26)=0.01, P=0.910).
Fmr1 knockout mice exhibit increased anxiety-related
behaviors during social interaction
Anxiety-related behaviors during social interaction, including
grooming, rearing and digging, were measured in each period of
the tests. During the sociability period (Fig. 3A) and the social
preference period (Fig. 3C), there were no significant differences in
grooming behavior between untreated wild-type mice and Fmr1
knockout mice. Comparing lithium treated wild-type mice to
untreated wild-type mice, there was no significant effect of lithium
treatment on grooming behavior (sociability: t(12)=0.201,
P=0.844; preference: t(12)=0.688, P=0.505). Fmr1 knockout
Figure 3. Fmr1 knockout mice exhibit increased social anxiety-related behaviors during social interaction. A. During the sociability
period, there was not a significant difference in grooming times of Fmr1 knockout (FX) mice and wild-type (WT) mice. Chronic lithium treatment had
no significant effect on WT grooming times but slightly decreased the percentage of FX mice with grooming times above the median time. Dashed
lines represent median grooming times, 12 sec and 12.5 sec for WT and FX mice, respectively. B. FX mice spent significantly more time rearing and
digging than WT mice during the sociability period. Chronic lithium treatment significantly decreased duration of rearing and digging behaviors in
both groups of mice. *p,0.05 compared to untreated group mates; ** p,0.05 comparing untreated WT and FX mice. C. During the social preference
period, there was not a significant difference in grooming times of Fmr1 knockout (FX) mice and wild-type (WT) mice. Chronic lithium treatment had
no significant effect on grooming times, but slightly decreased the percentage of WT and FX mice with grooming times above the median time.
Dashed lines represent median grooming times, 8.5 sec and 11 sec for WT and FX mice, respectively. D. FX mice spent significantly more time rearing
and digging than WT mice during the social preference period. Chronic lithium treatment significantly decreased duration of rearing and digging
behaviors in both groups of mice. * p,0.05 compared to untreated group mates; ** p,0.05 comparing untreated WT and FX mice.
doi:10.1371/journal.pone.0009706.g003
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grooming behaviors compared to untreated Fmr1 knockout mice
(sociability: t(13)=1.14, P=0.276; preference: t(13)=1.580,
P=0.138). Despite the overall lack of significant difference
between untreated wild-type mice and Fmr1 knockout littermates,
similarly to the results reported by McNaughton et al (2008), most
evident was the much broader range of interindividual differences
in the grooming times of Fmr1 knockout mice compared with wild-
type mice, and chronic lithium treatment reduced the interindi-
vidual variation in grooming times of Fmr1 knockout mice.
During both the first sociability period (Fig. 3B) and the social
preference period (Fig. 3D), Fmr1 knockout mice spent significantly
more time rearing and digging than wild-type mice (sociability:
t(16)=2.83, P=0.012; preference: t(16)=2.50, P=0.024). During
the first sociability period chronic lithium treatment reduced
rearing and digging behaviors of wild-type mice compared to
untreated wild-type mice (sociability: t(12)=3.43, P=0.005;
preference: t(12)=4.61, P=0.000) and significantly reduced the
rearing and digging times of Fmr1 knockout mice compared to
untreated Fmr1 knockout mice (sociability: t(13)=4.87, P=0.000;
preference.: t(13)=9.19, P=0.000). During the social preference
period, lithium treatment caused a ,55% decrease in time rearing
and digging for the wild-type mice and a ,54% decrease for the
Fmr1 knockout mice, eliminating the significant difference between
the genotypes (Fig. 3D). These data demonstrate that Fmr1
knockout mice exhibit more anxiety-related time rearing and
digging behaviors during social interaction than wild-type mice
that were reduced by chronic lithium treatment.
GSK3 knockin mice display normal sociability behaviors
To test if the decreased inhibitory serine-phosphorylation of
GSK3 in Fmr1 knockout mice is sufficient to cause the observed
deficits in socialization, social behaviors were measured with
GSK3 knockin mice, which have S21A-GSK3a and S9A-GSK3b
mutations, thereby disabling the inhibitory serine phosphorylation
of GSK3 (Fig. 4A). During the sociability period, there was no
significant interaction between genotype and chamber (F(2,
45)=2.521, P=0.092). GSK3 knockin mice spent similar times
Figure 4. Sociability is not altered in GSK3 knockin mice. A. GSK3 knockin mice lack serine-phosphorylation of GSK3 (PS-GSK3) on serine-21 of
GSK3a and on serine-9 of GSK3b, which is evident in wild-type mice, as reported previously [27,38]. Total GSK3 levels are equivalent in GSK3 knockin
mice and wild-type mice. B. Mean total time spent in each chamber during the sociability period. Wild-type (WT) (n=7) mice and GSK3 knockin (KI)
(n=10) mice spent significantly more time in Chamber 1, the chamber with S1, compared to empty Chamber 2 or Chamber 3 with the wire enclosure
only. * p,0.05 comparing time spent in Chamber 1 with Chambers 2 and 3. C. Social approach, the total number of nose contacts by the test mouse
with S1, was equivalent for untreated WT and KI mice. D. There was no difference in social interaction between WT and KI mice.
doi:10.1371/journal.pone.0009706.g004
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more time in Chamber 1 containing the S1 mouse than in
Chamber 3 containing only the wire enclosure (Fig. 4B, WT: F(2,
45)=117.29, P,0.001, GSK3 knockin: F(2, 45)=117.29,
P,0.001). There were also no significant differences between
wild-type mice and GSK3 knockin mice in social approach (the
number of nose contacts, Fig. 4C, t(15)=0.746, P=0.467) or
social interaction (average duration of nose contacts, Fig. 4D,
t(15)=0.220, P=0.829).
GSK3 knockin mice exhibit impaired social preference
Since Fmr1 knockout mice exhibited impaired social preference
(Fig. 2), we tested if this was also altered in GSK3 knockin mice.
There was no significant interaction between genotype and
chamber during this testing period (F(2, 57)=0.985, P=0.380).
Wild-type mice spent significantly more time in Chamber 3 with
the novel S2 mouse than in Chamber 1 with the familiar mouse
(Fig. 5A, F(2, 57)=45.620, P,0.001). In contrast, there was no
significant difference in the amount of time that GSK3 knockin
mice spent in Chamber 3 with the novel S2 mouse and in
Chamber 1 with the familiar S1 mouse (Fig. 5A, F(2, 57)=45.620,
P=0.111).
Assessment of social approach revealed that there was no
significant interaction between genotype and stimulus mouse (or
chamber of interaction, Fig. 5B, F(1, 34)=0.111, P=0.741).
GSK3 knockin mice did not exhibit a significant preference for
approaching S2 in Chamber 3 compared with S1 in Chamber 1
(F(1, 34)=3.566, P=0.266). There was also no significant
interaction between genotype and stimulus mouse (or chamber
or interaction) when assessing social interaction (the duration of
nose contacts) behavior (Fig. 5C, F(1, 34)=0.788, P=0.381).
Wild-type mice displayed a preference for social interaction with
S2 in Chamber 3, as demonstrated by the increased duration of
nose contacts with S2 compared with S1 (Fig. 5C, F(1,
34,)=5.336, P=0.035). GSK3 knockin mice displayed no
preference for the S2 stimulus mouse in Chamber 3 as indicated
Figure 5. GSK3 knockin mice exhibit impairments in social preference. A. Mean total time spent in each chamber during the social
preference period. Wild-type (WT) mice (n=11), but not GSK3 knockin (KI) mice (n=10), spent significantly more time in Chamber 3 with the novel S2
mouse compared to empty Chamber 2, or to Chamber 1 with the familiar (S1) mouse. * p,0.05 comparing time spent in Chamber 3 with Chambers 1
and 2. B. GSK3 KI mice display deficits in social approach preference, as indicated by no significant difference in the number of nose contacts with S1
or S2. C. The duration of nose contacts with S2 was significantly greater than with S1 for WT, but not GSK3 KI, mice. * p,0.05 comparing WT duration
of nose contacts with S1 and S2.
doi:10.1371/journal.pone.0009706.g005
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S2 (F(1, 34)=5.336, P=0.309). These results are similar to those
observed with the Fmr1 knockout mice, suggesting a possible
correlation between less inhibitory serine phosphorylation of
GSK3 and impaired social preference for a novel stimulus mouse.
GSK3 knockin mice display little anxiety-related
behaviors during social interaction
Fmr1 knockout mice exhibited greater anxiety-related behaviors
during social interaction than wild-type mice. Using the same
testing paradigm, we compared GSK3 knockin mice and wild-type
mice. There was no significant difference in time spent grooming
between wild-type and GSK3 knockin mice during the sociability
period with only S1 (Fig. 6A, t(17)=1.73, P=0.101), or during the
social preference period with S1 and S2 (Fig. 6C, t(17)=0.27,
P=0.790). During the first sociability period, wild-type mice spent
66% more time rearing and digging than the GSK3 knockin mice
(Fig. 6B, t(15)=2.46, P=0.027). During the social preference
period, there was no significant difference in rearing and digging
times between wild-type and GSK3 knockin mice (Fig. 6D,
t(17)=1.28, P=0.218). Collectively, there is little difference in
anxiety-related behaviors during social interaction in the GSK3
knockin mice compared to wild-type mice.
Discussion
Impairments in sociability have been identified previously in
Fmr1 knockout mice that appear to model some of the deficits in
social interactions characteristic of FXS and ASDs [12,13,15–19].
Since there is a need for more effective interventions for impaired
social behaviors than those currently available, we tested the
efficacy of lithium, an inhibitor of GSK3, because GSK3 is
hyperactive in Fmr1 knockout mouse brain and lithium amelio-
rates several other abnormal behaviors in Fmr1 knockout mice,
including hyperactivity, sensitivity to audiogenic seizures, and
impaired performance in a passive avoidance learning task
Figure 6. Anxiety-related behaviors during social interaction in GSK3 knockin mice. A. During the sociability period, there was not a
significant difference in grooming times of GSK3 knockin (KI) mice and wild-type (WT) mice, but the percentage of wild-type (WT) mice with
grooming times above the median was higher than GSK3 knockin (KI) mice. Dashed lines represent median grooming times, 12.5 sec. B. GSK3 KI mice
spent significantly less time rearing and digging than WT mice during the sociability period. * p,0.05 compared to untreated WT mice. C. During the
social preference period, there was not a significant difference in grooming times of GSK3 knockin (KI) mice and wild-type (WT) mice, but the
percentage of KI mice with grooming times above the median was slightly higher than WT controls. Dashed lines represent median grooming times,
12.5 sec. D. WT and GSK3 KI mice spent similar times rearing and digging during the social preference period.
doi:10.1371/journal.pone.0009706.g006
FX Social Behavior
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expressing hyperactive GSK3 [27] displayed any sociability
impairments resembling those of Fmr1 knockout mice. The results
obtained from these two experimental approaches indicate that
GSK3 may contribute to some aspects of social interaction
impairments, supporting the possibility that lithium, in combina-
tion with other interventions, may contribute to improved
sociability behaviors in patients with FXS or ASDs.
Although identifying differences in social behavior between
Fmr1 knockout and wild-type mice was not the main goal of this
study, as this has been addressed by several previous reports
[12,13,15–19], this aspect provided the necessary background for
our principal goal of testing whether social behaviors are
influenced by changes in the serine-phosphorylation of GSK3,
which regulates its activity. Upon examination of the results from
this and previous sociability studies of Fmr1 knockout mice, two
aspects stand out, (i) the limited magnitude, and (ii) the variability,
in reported social behavior differences between Fmr1 knockout and
wild-type mice. First, the most conspicuous aspect of social
behavior in Fmr1 knockout mice may be that differences from
wild-type mice are fairly subtle. This is in marked contrast to the
severity of deficits in social behaviors that are often evident in FXS
and ASDs [4–11,13]. This subtle impairment of sociability
behaviors matches the similarly modest deficits in learning tasks
displayed by Fmr1 knockout mice, although this is also a major
characteristic of FXS [21,31,32]. In contrast, Fmr1 knockout mice
appear to be an excellent model for the hyperactivity and seizure
susceptibility aspects of FXS. Second, it is also evident that there is
not a single aspect of altered sociability behavior in Fmr1 knockout
mice that has been found to be a robustly reproducible phenotype,
but instead somewhat different characteristics have been identified
in each report, likely in part due to the subtlety of their social
behavioral deficits. Spencer et al. (2005) reported that Fmr1
knockout mice exhibited increased social approach behavior,
decreased anxiety-like behaviors, and no difference in sociability,
compared to wild-type mice [16]. Extending their studies, Spencer
et al. (2008) reported that Fmr1 knockout mice had increased
locomotor activity, displayed less anxiety-like responses to novel
food, and exhibited increased social approach (or an increase in
the number of social approaches toward a novel cage-mate) than
their wild-type counterparts [18]. Expression of human FMRP,
using a yeast-artificial chromosome transgenic mouse model,
corrected several altered behaviors, including normalized locomo-
tor activity, normalized anxiety-like responses to novel food, and
normalized social approach [18]. Overall, the findings of this
group supported the conclusion that Fmr1 expression regulates
certain social behaviors. Mineur et al. (2002) reported increased
locomotor activity, decreased rearing, and decreased grooming
behaviors among Fmr1 knockout mice in the open field test,
compared to wild-type mice [15]. Using the partition interaction
test, with ovariectomized C3H female mice as the stimulus, this
group reported that Fmr1 knockout mice exhibited deficient social
interaction and impaired social preference [17]. McNaughton et al.
(2008) used the three-chambered social interaction box and
matched background and aged male mice as the stimulus and
reported no deficit in sociability, social approach, or social
preference in Fmr1 knockout mice [19]. Liu & Smith (2009) used
the three-chambered social behavior box and matched back-
ground, weight, and aged male mice as the stimulus and reported
decreased social approach, affected social preference, and
increased social anxiety in Fmr1 knockout mice [13]. Overall, a
clear consensus has not been reached on most sociability behaviors
displayed by Fmr1 knockout mice. Likely causes for these variable
results among laboratories have been discussed in detail
previously, focused primarily on methodological variables
[12,13,19,33]. For example, as detailed in those reports, the
sociability studies have varied in the background of the mice
studied, including C57Bl/6J X FVB/NJ [19], FVB/NJ [12,13],
and C57Bl/6J [12,15–18], the time of day tests were administered
(during the light cycle: [13,16,18]; or during the dark cycle: [19],
the age of the mice examined (2–3 months old: [12,13]; 3–4
months old: [12,15–18]; this study; 10–12 months old: [19]), and
other variable methods. These and other experimental variations
discussed previously [13,19] likely contribute to variable findings
among laboratories along with the subtlety of the social behavioral
impairments in the Fmr1 knockout mice. Thus, although the Fmr1
knockout mice have limitations in applications to studies of
possible therapeutic interventions for sociability aspects of FXS
and ADS, they remain the best model available until others are
developed.
The present study, using C57Bl/6J Fmr1 knockout mice and the
three-chambered social behavior apparatus during the dark cycle,
focused on testing whether GSK3 influences social behavior in
Fmr1 knockout mice. GSK3 was studied because inhibitory serine-
phosphorylation of GSK3 is impaired in Fmr1 knockout mouse
brains, and administration of GSK3 inhibitors controls other
behavior abnormalities in Fmr1 knockout mice [20,21]. The effects
of GSK3 on social behaviors were studied two ways. First, lithium,
a selective GSK3 inhibitor, was administered to wild-type and
Fmr1 knockout mice to test if it altered social behaviors. Lithium
also has other actions [34] that could conceivably contribute to its
effects on social behaviors. However, GSK3 is the most likely
target because lithium inhibits GSK3 in the brains of wild-type
and Fmr1 knockout mice [20,21], other GSK3 inhibitors reduce
audiogenic seizures and hyperactivity in Fmr1 knockout mice [20],
and GSK3 is the target of lithium’s therapeutic actions in other
disorders [34,35]. Second, we tested whether impaired inhibitory
control of GSK3 was sufficient to alter social behaviors similarly to
Fmr1 knockout mice by using GSK3 knockin mice, in which
GSK3 cannot be inhibited by serine-phosphorylation.
As in previous reports, only certain social behaviors were altered
in Fmr1 knockout mice. During the sociability period, wild-type
and Fmr1 knockout mice spent similarly greater times in the
chamber with the S1 stimulus mouse than in the empty chambers.
This confirms previous reports that Fmr1 knockout mice, like wild-
type mice, spend more time with another mouse than time alone
([12,13,19]. Introduction of a novel S2 stimulus mouse revealed a
deficit in social preference in Fmr1 knockout mice, as they spent
similar times with the novel S2 and with the familiar S1 mouse,
whereas wild-type mice preferred the novel mouse. Some, but not
all, previous studies have reported impaired social preference of
Fmr1 knockout mice [12,16,19], with variations likely due to
methodological and mouse strain differences [33]. Just as the
effects of lack of FMRP on social behavior are modest, so too was
the influence of altered GSK3 activity. Interestingly, GSK3
knockin mice displayed similar behaviors as Fmr1 knockout mice,
displaying equivalent sociability as wild-type mice with a single
stimulus mouse, but showing no preference for a novel mouse over
a familiar mouse. However, interpretation of the results with the
GSK3 knockin mice is limited by the impossibility of studying
littermates because of the double mutation in the homozygous
GSK3 knockin mice, which through environmental factors in the
home-cage could affect sociability. Nonetheless, it is interesting
that Fmr1 knockout mice and GSK3 knockin mice share the
phenotype of impaired social preference. This impaired preference
for a novel mouse could indicate an inability to discriminate
between familiar and novel mice, reduced interest in novelty, or
other causes, but the interesting point is that this behavioral
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GSK3 knockin mice, which both share increased GSK3 activation
levels in the brain. Taken together, these findings indicate that
GSK3 does not markedly influence sociability but impaired
inhibitory serine-phosphorylation of GSK3 in both Fmr1 knockout
mice and in GSK3 knockin mice is associated with a lack of social
preference for a novel mouse.
As with sociability and social preference, there were also
differential alterations in social approach in Fmr1 knockout mice
and in GSK3 knockin mice. Social approach in the presence of a
single stimulus mouse was not altered in Fmr1 knockout mice, but
they displayed a significant deficit in social approach to a novel
mouse during the social preference phase, thereby not preferring
the novel S2. These results are similar to previous reports that
Fmr1 knockout mice displayed less social approach behavior with a
novel mouse than wild-type mice [13,17]. Like Fmr1 knockout
mice, social approach also was unaltered in GSK3 knockin mice in
the presence of a single stimulus mouse, and GSK3 knockin mice
approached a novel second mouse less than did wild-type mice.
Thus, less inhibitory serine-phosphorylation of GSK3 in both Fmr1
knockout mice and GSK3 knockin mice is associated with lack of
preferential social approach with a novel mouse. Furthermore,
lithium treatment increased social approach in both Fmr1
knockout and wild-type mice. This is not due to increased
locomotor activity since lithium reduces open field activity in Fmr1
knockout mice and does not alter open field activity of wild-type
mice [20,21]. These results suggest that lower inhibitory serine-
phosphorylation of GSK3 contributes to impaired displays of
social preference.
Social avoidance among FXS and ASD patients may be partly
due to social anxiety experienced in social settings [33]. Fmr1
knockout mice displayed heightened anxiety-related behaviors
during social interaction, as a higher percentage of Fmr1 knockout
mice than wild-type littermates displayed greater grooming times
than the group median in both the sociability period and the social
preference period, and spent more time rearing and digging. This
is similar to the report of McNaughton et al. (2008) that a higher
percentage of FX mice exhibited grooming times higher than the
median in the presence of a stimulus mouse [19], and a report of
Fmr1 knockout mice exhibiting lower center mirror ratio and
decreased win percentages in the dominance tube test [16], which
indicated increased anxiety in Fmr1 knockout mice. However,
others found no elevation in social anxiety in Fmr1 knockout mice
[15,16,36]. The increased anxiety-related behaviors during social
interaction in Fmr1 knockout mice was not reflected in GSK3
knockin mice, indicating that impaired serine-phosphorylation of
GSK3 is not sufficient to increase anxiety-related behaviors during
social interaction. Nevertheless, inhibition of GSK3 by lithium
administration reduced anxiety-related behaviors during social
interaction in both wild-type and Fmr1 knockout mice during both
the sociability and social preference periods of testing. This
suggests that although dysregulated GSK3 alone is not sufficient to
cause anxiety-related behavior during social interaction, it can be
reduced by inhibition of GSK3 with lithium in Fmr1 knockout
mice.
In summary, this study found that both Fmr1 knockout mice and
GSK3 knockin mice display normal sociability with a single
stimulus mouse but do not display preference for a novel mouse.
Chronic lithium treatment modestly increased sociability and
more effectively reduced anxiety-related behaviors during social
interaction in Fmr1 knockout mice. Notably, a recent feasibility
trial of lithium in patients with FXS noted improvements in several
behaviors [37]. These findings provide the first identification of
links between GSK3 and social behaviors and suggest that
dysregulated GSK3 may contribute to some of the social
impairments associated with loss of FMRP and that these might
be partially remedied by lithium administration, also supporting
the utility of Fmr1 knockout as a means to identify mechanisms
underlying social impairments common among ASD and FXS




This study used adult, male C57Bl/6J littermates, ,3 months of
age, with or without a disruption of the Fmr1 gene (originally
kindly provided by Dr. W. Greenough, University of Illinois), or
homozygous GSK3a
21A/21A/b
9A/9A knockin mice (hereafter
referred to as GSK3 knockin mice; originally kindly provided
with matched controls by Dr. D. Alessi, University of Dundee) and
matched wild-type mice. The Fmr1 knockout mice were generated
by breeding male C57BL/6J hemizygous Fmr1 knockout mice and
female C57BL/6J heterozygous Fmr1 knockout mice to generate
male homozygous Fmr1 knockout mice and wild-type littermates.
Genotype was confirmed by PCR using the Jackson Laboratory
protocol for genotyping Fmr1 mice. The following primers were
used: mutant 59-CACGAGACTAGTGAGACGTG-39, wild-type
59-TGTGATAGAATATGCAGCATGTGA-39, common 59-
CTTCTGGCACCTCCAGCTT -39. Wild-type mice produce
amplicon products at 131 base pairs, Fmr1 knockout mice produce
amplicon products at 400 base pairs, and heterozygous mice
produce amplicons at 131 and 400 base pairs. GSK3 knockin mice
and matched wild-type mice of mixed C57Bl6, Balb/c, and Ba11
background [27] were generated by continuous inter-breeding of
homozygous knockin mice and wild-type mice of the same
background. The GSK3 knockin mice contain serine-to-alanine
mutations in the regulatory serines of both GSK3 isoforms, S21A-
GSK3a and S9A-GSK3b [27]. These mutations disable the
inhibitory serine phosphorylation of GSK3, but both isoforms are
expressed at normal levels so GSK3 retains maximal activities
within the normal physiological range. GSK3 knockin mice
reproduce and develop normally and no overt phenotype has been
reported. For chronic lithium treatment, mice were given ad libitum
water and saline (to prevent hyponatremia caused by lithium-
induced increased excretion of sodium) and were fed pelleted chow
containing 0.2% lithium carbonate (Teklad, Madison, WI) for
three weeks, as previously described [30,38]. All mice were housed
and treated in accordance with National Institutes of Health
guidelines and procedures with mice were approved by the
University of Alabama at Birmingham Institutional Animal Care
and Use Committee.
Behavior apparatus
A social interaction apparatus was used to assess sociability and
social preference of mice, as previously described [19]. The
apparatus (Fig. 1A) is a rectangular, transparent, Plexiglas box
divided by Plexiglas walls into three equal sized compartments
(24 cm length, 19 cm width, 19 cm height). Circular holes in the
Plexiglas walls provide access between the chambers. The floor of
the box was covered with a thin layer of bedding. All tests were
performed during the dark cycle with a 25 W red light bulb.
Sessions were recorded using a JVC mini camcorder on a MX 600
Tripod. The wire cages to house the stimulus mice were inverted,
circular pencil holders with bars spaced 1 cm apart (11 cm height,
10 cm diameter; Galaxy Cup, Spectrum Diversified Designs, Inc.,
Streetsboro, OH) and were present in each chamber at all times. A
clear, glass beaker was placed on top of each wire cage to prevent
FX Social Behavior
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70% ethanol and the bedding was changed.
Behavior testing
Habituation: Test mice were individually allowed to freely explore
the entire apparatus for 25 min the night prior to testing. Testing
was completed in a single 25 min session comprised of three
periods. Stimulus mice are confined to the small wire cages for
30 min each day for 5 days before the start of the test.
Rehabituation (5 min): The test mouse was placed in the center
chamber and allowed to freely explore the apparatus. The mouse
was never handled again until the conclusion of the test. When
stimulus mice were to be placed in a chamber, the test mouse was
gently coerced into the center chamber and confined from
entering the side chambers with 365 index cards covering the
inter-chamber openings.
Sociability (10 min): The test mouse was moved to the center
Chamber 2 with the connecting holes blocked. An unfamiliar ,3
month old male wild-type stimulus mouse 1 (S1) was placed in the
wire enclosure in Chamber 1, the connecting holes to both
Chambers 1 and 3 were opened, and the test mouse was allowed
to explore the entire apparatus for 10 min. This period assesses
socialization of the test mouse with the confined S1 mouse.
Social Preference (10 min): The test mouse was moved to the
center Chamber 2 with the connecting holes blocked. A second,
unfamiliar, wild-type stimulus mouse (S2) was placed in the wire
enclosure in Chamber 3 while S1 remained in the wire enclosure
in Chamber 1, the connecting holes were opened, and the test
mouse was allowed to explore the entire apparatus for 10 min.
This period assesses if the test mouse prefers to socialize more with
the novel S2 mouse than the familiar S1 mouse.
Data analysis
Each session was videotaped and videos were analyzed by pre-
trained investigators blind to the test mouse genotype and
treatment. Videos were quantitated for time spent in each
chamber, nose contact number (any engagement between the
nose of the test mouse and the confined stimulus mouse) and nose
contact duration (time from initiation to disengagement of nose
contacts), and cumulative time spent grooming, rearing, and
digging. Face washing and body grooming times were combined
for total grooming behavior times. Data were analyzed by two-way
ANOVA (Holm-Sidak posthoc test) with genotype and chamber as
factors or treatment and chamber as factors, or by Student’s t-test
(for social approach [number of nose contacts with an introduced
mouse] and social interaction [duration of nose contacts with an
introduced mouse] measurements in the sociability period and
anxiety-like behaviors) to determine statistically significant differ-
ences among groups.
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